Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 731

1.

miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.

Wang DT, Ma ZL, Li YL, Wang YQ, Zhao BT, Wei JL, Qi X, Zhao XT, Jin YX.

Oncol Rep. 2013 Jul;30(1):492-8. doi: 10.3892/or.2013.2453. Epub 2013 May 13.

PMID:
23670238
3.

miR-181a and miR-630 regulate cisplatin-induced cancer cell death.

Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupé P, Robert T, Ripoche H, Lazar V, Harel-Bellan A, Dessen P, Barillot E, Kroemer G.

Cancer Res. 2010 Mar 1;70(5):1793-803. doi: 10.1158/0008-5472.CAN-09-3112. Epub 2010 Feb 9.

4.

MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).

Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB.

Oncogene. 2011 Jun 9;30(23):2644-58. doi: 10.1038/onc.2010.642. Epub 2011 Feb 28.

PMID:
21358675
5.

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.

Liu J, Lu KH, Liu ZL, Sun M, De W, Wang ZX.

BMC Cancer. 2012 Nov 14;12:519. doi: 10.1186/1471-2407-12-519.

6.

PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer.

Xiong S, Zheng Y, Jiang P, Liu R, Liu X, Qian J, Gu J, Chang L, Ge D, Chu Y.

Br J Cancer. 2014 Jan 21;110(2):353-62. doi: 10.1038/bjc.2013.728. Epub 2013 Nov 26.

7.

MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.

He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan FK, Sung JJ, Yu J.

Mol Med. 2013 Feb 8;18:1491-8. doi: 10.2119/molmed.2012.00304.

8.

MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.

Wang LG, Ni Y, Su BH, Mu XR, Shen HC, Du JJ.

Int J Oncol. 2013 Mar;42(3):957-62. doi: 10.3892/ijo.2013.1767. Epub 2013 Jan 10.

PMID:
23314612
9.

MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.

Liu ZL, Wang H, Liu J, Wang ZX.

Mol Cell Biochem. 2013 Jan;372(1-2):35-45. doi: 10.1007/s11010-012-1443-3. Epub 2012 Sep 6.

PMID:
22956424
10.

miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer.

Liu F, Wang X, Li J, Gu K, Lv L, Zhang S, Che D, Cao J, Jin S, Yu Y.

Cell Prolif. 2015 Oct;48(5):582-92. doi: 10.1111/cpr.12201. Epub 2015 Aug 6.

PMID:
26250586
11.

MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2.

Ma ZL, Hou PP, Li YL, Wang DT, Yuan TW, Wei JL, Zhao BT, Lou JT, Zhao XT, Jin Y, Jin YX.

Tumour Biol. 2015 Apr;36(4):2481-90. doi: 10.1007/s13277-014-2861-5. Epub 2014 Dec 13.

PMID:
25501507
12.

MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer.

Zhang H, Zhang H, Zhao M, Lv Z, Zhang X, Qin X, Wang H, Wang S, Su J, Lv X, Liu H, Du W, Zhou W, Chen X, Fei K.

Cell Physiol Biochem. 2013;31(1):56-65. doi: 10.1159/000343349. Epub 2013 Jan 15.

13.

microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.

Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G, Fu S, Zhang Y, Feng K, Feng Y.

Eur J Cancer. 2014 Sep;50(13):2336-50. doi: 10.1016/j.ejca.2014.06.005. Epub 2014 Jul 4.

PMID:
25001183
14.

miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.

Lei L, Huang Y, Gong W.

Oncol Rep. 2013 Dec;30(6):2897-902. doi: 10.3892/or.2013.2755. Epub 2013 Sep 30.

PMID:
24084898
15.

Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.

Fortunato O, Boeri M, Moro M, Verri C, Mensah M, Conte D, Caleca L, Roz L, Pastorino U, Sozzi G.

Cell Death Dis. 2014 Dec 11;5:e1564. doi: 10.1038/cddis.2014.507.

16.

Effect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299.

Wang H, Li M, Zhang R, Wang Y, Zang W, Ma Y, Zhao G, Zhang G.

Tumour Biol. 2013 Oct;34(5):3101-9. doi: 10.1007/s13277-013-0878-9. Epub 2013 Jun 6.

PMID:
23740614
17.

MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.

Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY.

Cancer Res. 2007 Sep 15;67(18):8433-8. Epub 2007 Sep 6.

18.

Expression of miR-150 and miR-3940-5p is reduced in non-small cell lung carcinoma and correlates with clinicopathological features.

Sun Y, Su B, Zhang P, Xie H, Zheng H, Xu Y, Du Q, Zeng H, Zhou X, Chen C, Gao W.

Oncol Rep. 2013 Feb;29(2):704-12. doi: 10.3892/or.2012.2152. Epub 2012 Nov 28.

PMID:
23228962
19.

MicroRNA-449a is downregulated in non-small cell lung cancer and inhibits migration and invasion by targeting c-Met.

Luo W, Huang B, Li Z, Li H, Sun L, Zhang Q, Qiu X, Wang E.

PLoS One. 2013 May 29;8(5):e64759. doi: 10.1371/journal.pone.0064759. Print 2013.

20.

Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.

Yang T, Chen T, Li Y, Gao L, Zhang S, Wang T, Chen M.

Tumour Biol. 2015 Mar;36(3):1903-11. doi: 10.1007/s13277-014-2793-0. Epub 2014 Nov 29.

PMID:
25432132
Items per page

Supplemental Content

Write to the Help Desk